TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27527670

Group type: EXPERIMENTAL
Intervention: LNG 1.5mg as a single dose or in two doses 12h apart, up to 120h of unprotected intercourse
Number of subjects: 6873

Group type: EXPERIMENTAL
Intervention: LNG 1.5mg
Number of subjects: 6873
Study: 26620123

Group type: EXPERIMENTAL
Intervention: Screening arm (PSA measurements scheduled)
Number of subjects: 4276

Group type: COMPARATOR
Intervention: Control arm (no scheduled PSA measurements)
Number of subjects: 4276
Study: 25064681

Group type: EXPERIMENTAL
Intervention: Combination of medication and psychosocial intervention
Number of subjects: 1268

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 1268
Study: 22892337

Group type: EXPERIMENTAL
Intervention: Budesonide MMX 9 mg
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Budesonide MMX 6 mg
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Mesalamine 2.4 g
Number of subjects: 509

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 509
Study: 19487135

Group type: EXPERIMENTAL
Intervention: Aspiration plus intra‐articular injection of 3 mL of bupivacaine 0.5%
Number of subjects: 40

Group type: COMPARATOR
Intervention: Aspiration alone
Number of subjects: 40
Study: 17617807

Group type: EXPERIMENTAL
Intervention: Measles vaccine ROUVAX
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 12
Study: 15734608

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 12848629

Group type: EXPERIMENTAL
Intervention: 9-month treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: 15-month treatment
Number of subjects: 40
Study: 10771366

Group type: EXPERIMENTAL
Intervention: Intervention group (I-group)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 85
Study: 8876936

Group type: EXPERIMENTAL
Intervention: Fluvastatin
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Bezafibrate
Number of subjects: 8

Group type: COMPARATOR
Intervention: Diet/Placebo
Number of subjects: 8
Study: 1524654

Group type: EXPERIMENTAL
Intervention: Biperiden
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 6380210

Group type: EXPERIMENTAL
Intervention: Diclofenac 100 mg immediately postoperatively, followed by 50 mg in the evening and 50 mg in the morning after the operation
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo suppositories
Number of subjects: 97
Study: 30745277

Group type: EXPERIMENTAL
Intervention: MenAfriVac vaccination in children aged 12–23 months
Number of subjects: 797

Group type: EXPERIMENTAL
Intervention: MenAfriVac vaccination in participants aged 2–29 years
Number of subjects: 797

Group type: EXPERIMENTAL
Intervention: MenAfriVac vaccination
Number of subjects: 797
Study: 30042225

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon
Number of subjects: 285

Group type: COMPARATOR
Intervention: Control balloon (uncoated)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 285
Study: 24926658

Group type: EXPERIMENTAL
Intervention: Social skills intervention
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Playground engagement scores at entry and midpoint of treatment
Number of subjects: 92
Study: 23954387

Group type: EXPERIMENTAL
Intervention: Oxiplex/AP gel (Intercoat)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control (no gel)
Number of subjects: 52
Study: 22011772

Group type: EXPERIMENTAL
Intervention: Mild hypothermic cardiopulmonary bypass (CPB) (Mi > 32 °C, n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Moderate hypothermic cardiopulmonary bypass (CPB) (Mo > 26 °C, n = 20)
Number of subjects: 40
Study: 20416952

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab (ivB)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Modified Early Treatment of Diabetic Retinopathy Study (ETDRS) macular laser therapy (MLT)
Number of subjects: 80
Study: 18625518

Group type: EXPERIMENTAL
Intervention: Cervical injection
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Hysteroscopic injection
Number of subjects: 54
Study: 16143698

Group type: EXPERIMENTAL
Intervention: Clopidogrel (300 mg loading dose, then 75 mg once daily)
Number of subjects: 1863
Study: 11845882

Group type: EXPERIMENTAL
Intervention: Standard treatment for heart failure
Number of subjects: 26

Group type: COMPARATOR
Intervention: Propranolol (additional treatment)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Group 1 (ICU stay < 7 days)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Group 2 (ICU stay > 7 days + deaths)
Number of subjects: 26
Study: 10429977

Group type: EXPERIMENTAL
Intervention: IL-2 treatment
Number of subjects: 21
Study: 7481190

Group type: EXPERIMENTAL
Intervention: Markov chain model for estimating mean sojourn time (MST)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional method for estimating mean sojourn time
Number of subjects: 0
Study: 2115308

Group type: EXPERIMENTAL
Intervention: Metrifonate (10 mg/kg, repeated at 4 month intervals)
Number of subjects: 1813

Group type: EXPERIMENTAL
Intervention: Praziquantel (1 dose of 40 mg/kg)
Number of subjects: 1813
Study: 6108266

Group type: EXPERIMENTAL
Intervention: Ketazolam given once daily
Number of subjects: 56

Group type: COMPARATOR
Intervention: Diazepam given three times a day
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ketazolam
Number of subjects: 56

Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 56
Study: 28980034

Group type: EXPERIMENTAL
Intervention: ALA-GLN dipeptide supplementation
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control (no ALA-GLN dipeptide supplementation)
Number of subjects: 98
Study: 28614554

Group type: EXPERIMENTAL
Intervention: Problem-solving education (PSE) intervention
Number of subjects: 230

Group type: COMPARATOR
Intervention: Usual Head Start services
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Problem-solving education (PSE) intervention (lower-level baseline symptoms)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Usual Head Start services (lower-level baseline symptoms)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Problem-solving education (PSE) intervention (higher-level baseline symptoms)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Usual Head Start services (higher-level baseline symptoms)
Number of subjects: 230
Study: 26130119

Group type: EXPERIMENTAL
Intervention: Impaired left ventricular longitudinal strain (LS) defined as an absolute LS <15.8%
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Impaired left ventricular longitudinal strain (LS)
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 447
Study: 23249655

Group type: EXPERIMENTAL
Intervention: Iyengar yoga (9-week course)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Home-based exercise (self-care manual)
Number of subjects: 51
Study: 20092985

Group type: EXPERIMENTAL
Intervention: KalmCold (200 mg/day)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 223
Study: 18850387

Group type: EXPERIMENTAL
Intervention: Follicular phase premenopausal women
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Oral contraceptive treatment for 2 months (premenopausal women)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Sequential therapy (postmenopausal women)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Estrogen-only therapy (postmenopausal women)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 81
Study: 16897235

Group type: COMPARATOR
Intervention: Propofol alone (group P)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 66% nitrous oxide with propofol (group PN)
Number of subjects: 16
Study: 14535021

Group type: EXPERIMENTAL
Intervention: 654‐2 injection and 'Gan Xian Tui Huang Recipe'
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine treatment (Control)
Number of subjects: 60
Study: 10913808

Group type: EXPERIMENTAL
Intervention: Therapy A
Number of subjects: 0

Group type: COMPARATOR
Intervention: Therapy B
Number of subjects: 0
Study: 8775240

Group type: EXPERIMENTAL
Intervention: Intraumbilical 20 IU of oxytocin diluted to 40 mL with saline
Number of subjects: 72

Group type: COMPARATOR
Intervention: Intraumbilical vein 40 mL of saline
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard protocol without any intraumbilical injection
Number of subjects: 72
Study: 1290181

Group type: EXPERIMENTAL
Intervention: Pulsatile perfusion
Number of subjects: 80

Group type: COMPARATOR
Intervention: Nonpulsatile perfusion
Number of subjects: 80
Study: 6463852

Group type: EXPERIMENTAL
Intervention: Vitrectomy for chronic aphakic cystoid macular edema
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 130
Study: 31561398

Group type: EXPERIMENTAL
Intervention: Dance Group (DG)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 33
Study: 29351790

Group type: EXPERIMENTAL
Intervention: QuinteT Recruitment Intervention (QRI)
Number of subjects: 8
Study: 27462065

Group type: EXPERIMENTAL
Intervention: Technology-assisted quality improvement (QI) intervention
Number of subjects: 577

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Technology-assisted QI intervention
Number of subjects: 577
Study: 24103017

Group type: EXPERIMENTAL
Intervention: Imiquimod treatment
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Optical coherence tomography (OCT) imaging
Number of subjects: 20
Study: 22551036

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 265

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 265
Study: 19703824

Group type: EXPERIMENTAL
Intervention: INTERdisciplinary COMmunity‐based COPD management programme (INTERCOM)
Number of subjects: 199

Group type: COMPARATOR
Intervention: usual care
Number of subjects: 199
Study: 19022121

Group type: EXPERIMENTAL
Intervention: Piezoelectric osteotomy technique
Number of subjects: 100

Group type: COMPARATOR
Intervention: Rotatory osteotomy technique
Number of subjects: 100
Study: 17038243

Group type: EXPERIMENTAL
Intervention: Standard nutrition support + Gln 100 ml/d + rhGH 10 U/d (Group C)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard nutrition support (Group A)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard nutrition support + 10% Gln 100 ml/d (Group B)
Number of subjects: 90
Study: 12812018

Group type: EXPERIMENTAL
Intervention: Transdermal Nicotine System (TNS) for 3 weeks
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Transdermal Nicotine System (TNS) for 6 weeks
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo for 3 weeks
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo for 6 weeks
Number of subjects: 160
Study: 11157426

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 186

Group type: COMPARATOR
Intervention: Control drugs (tricyclics/heterocyclics and SSRIs)
Number of subjects: 186
Study: 9135526

Group type: EXPERIMENTAL
Intervention: Palliative external beam radiotherapy (30 Gy in 10 fractions)
Number of subjects: 67

Group type: COMPARATOR
Intervention: No radiotherapy
Number of subjects: 67
Study: 8116276

Group type: EXPERIMENTAL
Intervention: Monocular viewing of a simulated object with varying speed
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Monocular viewing of a simulated object with removed cues
Number of subjects: 7
Study: 3299016

Group type: EXPERIMENTAL
Intervention: MK-733 (low dose: 2.5-10 mg/day)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: MK-733 (high dose: 20-80 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 30829057

Group type: EXPERIMENTAL
Intervention: Letermovir (prophylactic treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study: 28624696

Group type: EXPERIMENTAL
Intervention: Concomitant administration of trastuzumab and taxane chemotherapy
Number of subjects: 5502

Group type: COMPARATOR
Intervention: Sequential administration of trastuzumab after chemotherapy
Number of subjects: 5502
Study: 25933389

Group type: EXPERIMENTAL
Intervention: Original brand placebo (500 mg Aspirin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Generic placebo (1A Pharma)
Number of subjects: 0
Study: 23057419

Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ)
Number of subjects: 118
Study: 21705493

Group type: EXPERIMENTAL
Intervention: 800 mg of intravenous iron (III)-hydroxide sucrose
Number of subjects: 90

Group type: COMPARATOR
Intervention: Intravenous placebo
Number of subjects: 90
Study: 18778396

Group type: COMPARATOR
Intervention: Atorvastatin 40 mg
Number of subjects: 75
Study: 16957676

Group type: EXPERIMENTAL
Intervention: Estromineral serena (ES) - 1 tablet/day for 24 weeks
Number of subjects: 89

Group type: COMPARATOR
Intervention: Calcium + Vitamin D3 (Ca+D) - 1 tablet/day for 24 weeks
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Estromineral serena (ES)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Calcium + Vitamin D3 (Ca+D)
Number of subjects: 89
Study: 15077843

Group type: EXPERIMENTAL
Intervention: Outpatient substance abuse treatment
Number of subjects: 140
Study: 11304940

Group type: EXPERIMENTAL
Intervention: Climodien (estradiol valerate 2 mg + dienogest 3 mg)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Climodien (estradiol valerate 2 mg + dienogest 2 mg)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 9034258

Group type: EXPERIMENTAL
Intervention: 4% albumin solution (0.6 g/kg) administered after withdrawing 15 mL/kg of blood over 30 mins in group 2.
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (group 1) without hemodilution.
Number of subjects: 26
Study: 8509529

Group type: EXPERIMENTAL
Intervention: Sotalol plus quinidine
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Sotalol plus procainamide
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Sotalol plus quinidine or procainamide
Number of subjects: 50

Group type: COMPARATOR
Intervention: Alternative therapy after combination therapy was discontinued
Number of subjects: 50
Study: 30943512

Group type: EXPERIMENTAL
Intervention: Surgical treatment of the primary tumour and lymph nodes metastasis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-surgical approaches (including radiotherapy and systemic medical treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy and radiotherapy
Number of subjects: 0
Study: 28829248

Group type: EXPERIMENTAL
Intervention: Actual Week test
Number of subjects: 58
Study: 27019066

Group type: EXPERIMENTAL
Intervention: Citalopram infusion
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 8
Study: 24440083

Group type: EXPERIMENTAL
Intervention: Preoperative pelvic floor muscle training (PFMT), three times a day for four weeks, 30 days before RP
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Preoperative pelvic floor muscle training (PFMT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control Group (routine pre‐surgical education)
Number of subjects: 16
Study: 21401720

Group type: EXPERIMENTAL
Intervention: rATG(S)
Number of subjects: 98
Study: 20195019

Group type: EXPERIMENTAL
Intervention: Perturbation training in conjunction with strength-training exercises (PERT group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Progressive quadriceps strength-training exercises (STR group)
Number of subjects: 40
Study: 16996783

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis combined with pre and postsurgery hyperbaric oxygen (HBO) treatment
Number of subjects: 26

Group type: COMPARATOR
Intervention: Antibiotic prophylaxis
Number of subjects: 26
Study: 16199795

Group type: EXPERIMENTAL
Intervention: Venlafaxine ER (75‐225 mg/day)
Number of subjects: 361

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 361
Study: 12022898

Group type: EXPERIMENTAL
Intervention: Regular coffee (180 mg caffeine in 200 mL beverage)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Decaffeinated coffee (3.6 mg caffeine in 200 mL beverage)
Number of subjects: 28
Study: 10427296

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation programme
Number of subjects: 0
Study: 8521744

Group type: EXPERIMENTAL
Intervention: Teicoplanin (400 mg once daily)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Flucloxacillin (with or without fusidic acid)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Flucloxacillin + fusidic acid
Number of subjects: 56
Study: 1968308

Group type: COMPARATOR
Intervention: Dopamine infusion at 0.04, 0.4, and 4.0 micrograms.kg‐1.min‐1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Metoclopramide (10 mg) after 17 h during dopamine infusion
Number of subjects: 30

Group type: COMPARATOR
Intervention: Fenoldopam (0.5 micrograms.kg‐1.min‐)
Number of subjects: 30
Study: 7191311

Group type: EXPERIMENTAL
Intervention: Acemetacin (180 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Indometacin (150 mg/day)
Number of subjects: 40
Study: 30763545

Group type: EXPERIMENTAL
Intervention: My Birth Control (intervention)
Number of subjects: 758

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 758
Study: 30286145

Group type: EXPERIMENTAL
Intervention: Tube lubricated with water
Number of subjects: 296

Group type: COMPARATOR
Intervention: Tube without lubrication
Number of subjects: 296
Study: 26555945

Group type: EXPERIMENTAL
Intervention: Sirolimus (group B)
Number of subjects: 525

Group type: COMPARATOR
Intervention: Mammalian target of rapamycin inhibitor-free immunosuppression (group A)
Number of subjects: 525
Study: 25275972

Group type: COMPARATOR
Intervention: Corticosteroid injection
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Hyaluronate injection
Number of subjects: 68
Study: 22746387

Group type: EXPERIMENTAL
Intervention: Mitomycin C (MMC) monotherapy
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Alternating mitomycin C (MMC) and bacillus Calmette-Guérin (BCG) instillations
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 68
Study: 20194881

Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 672

Group type: COMPARATOR
Intervention: Glipizide
Number of subjects: 672
Study: 17403819

Group type: EXPERIMENTAL
Intervention: Drainage, irrigation, and fibrinolytic therapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard therapy (tapping of cerebrospinal fluid by reservoir)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 70
Study: 15728301

Group type: EXPERIMENTAL
Intervention: Proband-initiated contact strategy; Phase 1: 99 proband enrollment forms; Phase 2: 50 sibling reply cards.
Number of subjects: 99
Study: 11985761

Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 57

Group type: COMPARATOR
Intervention: Strength training
Number of subjects: 57
Study: 9616309

Group type: EXPERIMENTAL
Intervention: Budesonide (3 x 1 mg/day)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 179
Study: 8706113

Group type: EXPERIMENTAL
Intervention: Cold pressor test (CPT)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Cold pressor test (CPT) with clonidine pretreatment
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 27
Study: 2558829

Group type: EXPERIMENTAL
Intervention: LMWH-low: 3,000 aXa U
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: LMWH-medium: 4,000 aXa U
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: LMWH-high: 5,000 aXa U
Number of subjects: 20

Group type: COMPARATOR
Intervention: UFH regimen: 5,000 IU bolus and 1,500 IU/h infusion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: All regimens (including UFH)
Number of subjects: 20
Study: 911730

Group type: EXPERIMENTAL
Intervention: Pilocarpine and phenylephrine drops
Number of subjects: 58

Group type: COMPARATOR
Intervention: Dummy provocative test (Control)
Number of subjects: 58
Study: 31944081

Group type: EXPERIMENTAL
Intervention: Potassium sulfate at 180 kg ha‐1 K2O
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Potassium chloride at 180 kg ha‐1 K2O
Number of subjects: 3

Group type: COMPARATOR
Intervention: No potassium fertilization
Number of subjects: 3
Study: 30700946

Group type: EXPERIMENTAL
Intervention: Mediterranean diet for 16 weeks
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Low-fat diet for 16 weeks
Number of subjects: 20
Study: 30376755

Group type: EXPERIMENTAL
Intervention: Successful Kinesthetic Instruction for Preschoolers (SKIP) intervention (360 min total over 6 weeks, 30-min sessions twice weekly)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 107
Study: 25931239

Group type: EXPERIMENTAL
Intervention: SWIFT Cast
Number of subjects: 105

Group type: COMPARATOR
Intervention: Conventional Physical Therapy (CPT)
Number of subjects: 105
Study: 25330506

Group type: EXPERIMENTAL
Intervention: CRS‐TAVR for severe aortic regurgitation (AR)
Number of subjects: 26
Study: 23250018

Group type: EXPERIMENTAL
Intervention: Vibrosphère™ rehabilitation for 9 days
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Classical revalidation for 9 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group of 20 non-faller subjects aged 79.9
Number of subjects: 24
Study: 20303646

Group type: EXPERIMENTAL
Intervention: Second TUR (performed within 2-6 weeks after initial resection)
Number of subjects: 210

Group type: COMPARATOR
Intervention: No second TUR
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Second TUR
Number of subjects: 210
Study: 17321065

Group type: EXPERIMENTAL
Intervention: Nodal ratio (NR) < or = 0.20
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: Nodal ratio (NR) > or = 0.20
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: Nodal positivity using NR
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: Nodal ratio >0.20
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: Cox regression analysis
Number of subjects: 544
Study: 16863974

Group type: EXPERIMENTAL
Intervention: Microincision cataract surgery (MICS) technique
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard stop‐and‐chop phacoemulsification
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Overall sample
Number of subjects: 80
Study: 12578926

Group type: EXPERIMENTAL
Intervention: Mild Cognitive Impairment (MCI)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Cognitively Normal Older Controls
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Patients with Alzheimer's Disease (AD)
Number of subjects: 64